A phase III study of Dupilumab in chronic obstructive pulmonary disease (COPD)
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Dupilumab (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 07 Feb 2018 According to a Sanofi media release, this study is planned to initiate in Q4 2018.
- 18 Dec 2017 New trial record
- 13 Dec 2017 According to a Regeneron Pharmaceuticals media release, this trial is planned to initiate in 2018.